Bringing the fundamentals into focus…
Back to Relay Therapeutics, Inc.
How Relay Therapeutics, Inc. stacks up
RLAY · against 249 other Healthcare companies of similar size
Growth
90/ 100
Near the top of its peers.
Ranked #30 of 250 · scores higher than 87% of peers
Bars: peers in each 10-point band of the growth score34 peers with a growth score of 90–100, including RLAY · Click a bar to see the companies
Why growth scores 90?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 82% of peers. Revenue growth: 23.9% vs peer median 6.1%
- faster revenue growth over three years: stronger than 97% of peers. 3-year revenue growth: 122.3% vs peer median 5.8%
Metric by metric
Position: dot = RLAY, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RLAY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 249 reported | 23.9% | 7.7% | 81% | 33% | |
| Earnings per share growthHigher is better · 159 reported | Not reported | 11.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 244 reported | 122.3% | 8.3% | 97% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around RLAY| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 2 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 25 | 4.0B USD | 91 | 72 | |
| 30 | 6.3B USD | 90 | 78 | |
| 30 | 5.7B USD | 90 | 30 | |
| 30 | 7.4B USD | 90 | 67 | |
| 30 | 3.8B USD | 90 | 48 | |
| 30 | 2.1B USD | 90 | 61 | |
| 35 | 18.7B CNY (≈$2.6B) | 89 | 51 | |
| 35 | 2.4B EUR (≈$2.6B) | 89 | 69 | |
| 35 | 7.0B USD | 89 | 57 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score